Literature DB >> 18847346

A murine monoclonal antibody that binds N-terminal extracellular segment of human protease-activated receptor-4.

Takeshi Sangawa1, Terukazu Nogi, Junichi Takagi.   

Abstract

Abstract A monoclonal antibody that recognizes native G protein coupled receptors (GPCR) is generally difficult to obtain. Protease-activated receptor-4 (PAR4) is a GPCR that plays an important role in platelet activation as a low-affinity thrombin receptor. By immunizing peptide corresponding to the N-terminal segment of human PAR4, we obtained a monoclonal antibody that recognizes cell surface expressed PAR4. Epitope mapping using a series of artificial fusion proteins that carry PAR4-derived peptide revealed that the recognition motif is fully contained within the 6-residue portion adjacent to the thrombin cleavage site. The antibody blocked PAR4 peptide cleavage by thrombin, suggesting its utility in the functional study of PAR4 signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18847346     DOI: 10.1089/hyb.2008.0027

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  3 in total

1.  Protease-activated receptors in cancer: A systematic review.

Authors:  Na Han; Ketao Jin; Kuifeng He; Jiang Cao; Lisong Teng
Journal:  Oncol Lett       Date:  2011-04-08       Impact factor: 2.967

2.  Novel affinity tag system using structurally defined antibody-tag interaction: application to single-step protein purification.

Authors:  Terukazu Nogi; Takeshi Sangawa; Sanae Tabata; Masamichi Nagae; Keiko Tamura-Kawakami; Ayako Beppu; Mitsuharu Hattori; Norihisa Yasui; Junichi Takagi
Journal:  Protein Sci       Date:  2008-09-11       Impact factor: 6.725

3.  Structure of the Plexin Ectodomain Bound by Semaphorin-Mimicking Antibodies.

Authors:  Kei Suzuki; Hiroyuki Tsunoda; Ryusuke Omiya; Kyoko Matoba; Takeshi Baba; Sachiyo Suzuki; Hiroaki Segawa; Atsushi Kumanogoh; Kenji Iwasaki; Kunihiro Hattori; Junichi Takagi
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.